English
Etrolizumab Biosimilar - Research Grade
Etrolizumab Biosimilar - Research Grade, Human IgG1(KDel)-Kappa
Artikelnummer
ICH5150-10MG
Verpackungseinheit
10mg
Hersteller
Ichorbio
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Target: ITGA4/ITGB7.
Specificity: Detects human ITGA4/ITGB7.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Etrolizumab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Specificity: Detects human ITGA4/ITGB7.
Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background: Uses the same sequence as the therapeutic antibody Etrolizumab.
Concentration: 5mg/ml.
Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.
Endotoxin: <1EU/mg Determined by LAL gel clotting assay.
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
